Aortic Repair Devices – Market Insights – Asia Pacific

The Asia Pacific aortic repair device market is projected to experience robust growth during the forecast period, fueled by rising endovascular procedure volumes, ongoing innovation in aortic stent graft technology, and changes in the prices of endovascular grafts. Notably, this iteration of the forecast incorporates the anticipated launch of endovascular aortic stent grafts for the treatment of ascending aortic aneurysms, a segment that is expected to meaningfully expand the addressable market and procedural opportunity across the region once commercially available. Nevertheless, several factors will partially constrain procedural growth, including insufficient numbers of physicians trained in endovascular methods, limited aneurysm awareness and screening programs, and budget-restricted healthcare infrastructure across select covered markets.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for aortic repair devices in the Asia Pacific from 2019 to 2035.

The aortic stent graft market is driven by continuous innovation, with companies introducing devices capable of treating increasingly complex aneurysms.

Which types of aortic stent grafts are currently available in the Asia Pacific, and for which anatomies?

How will the introduction of new branched stent grafts drive the adoption of customized procedures in each country?

How will these products influence the volume of aortic surgical procedures?

The anticipated entry of innovative devices is expected to address unmet needs in the aortic repair device market.

Once introduced, how will aortic stent grafts for the ascending aorta impact procedural trends?

To what extent will these devices reshape the competitive landscape in the coming years?

How will the launch of an endograft for the ascending aorta affect the surgical graft market?

The generation of long-term clinical evidence will determine physicians’ preferences.

How will the results of completed and ongoing trials affect aortic repair market trends across the Asia Pacific?

How have regulatory and clinical guidance frameworks from bodies such as the NMPA, CDSCO, TGA, and MFDS shaped physician treatment decisions and device uptake across the Asia Pacific region?

The endovascular treatment of aortic aneurysms will expand robustly during the forecasted period.

For which indications will endovascular procedures experience the highest growth?

What impact will the increasing availability of branched endografts have on the competitive landscape in the coming years?

Which country will see the fastest growth of endovascular aortic repair procedures?